A novel three-dose regimen of daclizumab in liver transplant recipients with hepatitis C: a pharmacokinetic and pharmacodynamic study.

Source:http://linkedlifedata.com/resource/pubmed/id/16456831

Download in:

View as

Triples

General Info

PMID
16456831